Sector consensus Abbisko Cayman Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 08:08:22 16/03/2026 GMT			5-day change	1st Jan Change
12.32 ^HKD	+1.65%		+3.70%	-5.30%

01:46am	Abbisko Doses First Patient in Liver Cancer Drug Trial	MT
03-11	Abbisko Drug Receives Rare Pediatric Designation in U.S.	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
ABBISKO CAYMAN LIMITED			21.25	+98.7%	10
ARGENX SE			841.08	+37.03%	15
WUXI APPTEC CO., LTD.			133.13	+46.5%	18
INSMED INCORPORATED			213	+52.69%	19
BIONTECH SE			113.23	+42.05%	18
WUXI BIOLOGICS (CAYMAN) INC.			39.71	+30.59%	24
GENMAB A/S			2,229.78	+30.97%	14
AKESO, INC.			153.88	+58.36%	21
SUMMIT THERAPEUTICS INC.			23.49	+94.72%	13
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			536.92	+36%	17
EXELIXIS, INC.			46.83	+13.56%	18
MADRIGAL PHARMACEUTICALS, INC.			667.57	+50.07%	14
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	770,000	+44.74%	1
IMMUNITYBIO, INC.			14.8	+76.4%	5
REMEGEN CO., LTD.			86.69	+11.24%	15
VAXCYTE, INC.			109	+99.71%	9
ARROWHEAD PHARMACEUTICALS, INC.			81.36	+47.8%	11
NUVALENT, INC.			143.94	+46.98%	17
PHARMAESSENTIA CORPORATION			757	+15.22%	7
CYTOKINETICS, INCORPORATED			91.61	+52.53%	18
Average			38,815.21	+49.29%	14
Weighted average by Cap.			23,709.68	+45.51%	16